Stine Brændegaard Winther

TAS-102 with or without bevacizumab in patients with chemorefractory metastatic colorectal cancer: an investigator-initiated, open-label, randomised, phase 2 trial

Per Pfeiffer, Mette Yilmaz, Sören Möller et al. · The Lancet Oncology · 2020 · 231 citations

Medicine, Oncology, Pharmacology +10

Reduced-dose combination chemotherapy (S-1 plus oxaliplatin) versus full-dose monotherapy (S-1) in older vulnerable patients with metastatic colorectal cancer (NORDIC9): a randomised, open-label phase 2 trial

Stine Brændegaard Winther, Gábor Liposits, Halla Skúladóttir et al. · ˜The œLancet. Gastroenterology & hepatology · 2019 · 73 citations

Medicine, Geriatric Medicine, Oncology +14

Trends in colorectal cancer in the elderly in Denmark, 1980–2012

Stine Brændegaard Winther, Gunnar Baatrup, Per Pfeiffer et al. · Acta Oncologica · 2016 · 48 citations · Full text

Medicine, Geriatric Medicine, Oncology +17

Frailty screening for predicting rapid functional decline, rapid progressive disease, and shorter overall survival in older patients with gastrointestinal cancer receiving palliative chemotherapy - a prospective, clinical study

Eva Jespersen, Stine Brændegaard Winther, Lisbeth Rosenbek Minet et al. · Journal of Geriatric Oncology · 2020 · 34 citations

Medicine, Geriatric Medicine, Oncology +17

Quality of Life in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy—The Randomized NORDIC9-Study

Gábor Liposits, Henrik Eshøj, Sören Möller et al. · Cancers · 2021 · 21 citations · Full text

Medicine, Geriatric Medicine, Oncology +17